CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
California Life Sciences Thanks Congress for Passing Legislation to Protect Research Incentives for the Development of Innovative New Treatments and Products
Jul 9, 2025
FOR IMMEDIATE RELEASE: Jul 9, 2025 Washington, DC – California institutions play an outsized role in supporting innovation and the development of new products and therapies that benefit human health. However, in..
Read MoreSenator Becker Announces OBAL Winner, Introduces Legislation to Expand Healthcare Access for Farmworkers in Rural California
Mar 11, 2025
FOR IMMEDIATE RELEASE: Mar 11, 2025 Sacramento, CA – Today, Senator Josh Becker (D-Menlo Park) announced the winner of the “There Ought to be a Law” (OBAL) competition for 2025...
Read MoreCalifornia Life Sciences Celebrates Rare Disease Week, Promotes Innovation and Access for Patients
Feb 28, 2025
FOR IMMEDIATE RELEASE: Feb 28, 2025 South San Francisco – California Life Sciences (CLS) celebrates what has been a critically important and fulfilling rare disease week spent advocating for access..
Read MoreCouncil on State Biotechnology Associations says NIH Funds are a Critical Component of Innovation Ecosystem
Feb 20, 2025
Today, the US biotech industry employs nearly 2.3 million people across the US and is making positive contributions to economic impact and national security across all 50 states. In fact,..
Read MoreCalifornia Life Sciences’ Statement Regarding NIH Research Funding
Feb 13, 2025
FOR IMMEDIATE RELEASE: Feb 13, 2025 South San Francisco, CA – California Life Sciences (CLS) today released the following statement regarding recent actions that could jeopardize National Institutes of Health research..
Read More